KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $113,436 | -47.0% | 14,432 | +61.8% | 0.00% | -100.0% |
| Q2 2021 | $214,000 | -64.9% | 8,919 | -62.4% | 0.00% | -75.0% |
| Q1 2021 | $610,000 | +238.9% | 23,741 | +59.8% | 0.00% | +33.3% |
| Q2 2020 | $180,000 | -69.0% | 14,853 | -80.4% | 0.00% | -80.0% |
| Q1 2020 | $581,000 | -73.5% | 75,910 | -38.3% | 0.02% | +15.4% |
| Q4 2019 | $2,191,000 | +52.5% | 123,043 | -0.7% | 0.01% | 0.0% |
| Q3 2019 | $1,437,000 | -8.9% | 123,887 | +73.9% | 0.01% | -13.3% |
| Q2 2019 | $1,578,000 | – | 71,244 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |